2′-O-Acetylated RNA Composition for Stable Repeated Dosing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current RNA therapeutics face challenges due to short-lived activity and instability, primarily attributed to the reactivity of the hydroxyl group on carbon 2 of the ribose in ribonucleotides, leading to issues such as RNA autohydrolysis and nuclease degradation.
Innovation Solution
The introduction of 2′-O-acetylated ribonucleotides, which maintain crucial hydrogen bonding interactions while reducing reactivity, thereby enhancing stability and reducing immunogenicity, allowing for increased expression, persistence, and reduced dosing frequency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If 2′-O-acetylated nucleotides are used to reduce RNA reactivity and enhance stability, then the stability and persistence of RNA therapeutics is improved, but the complexity of RNA production and manufacturing increases
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of ribonucleotides through 2′-O-acetylation. This chemical modification changes the reactivity parameter of the hydroxyl group on carbon 2 of the ribose, reducing its susceptibility to nuclease degradation and autohydrolysis. The acetylation parameter change directly enhances RNA stability while maintaining hydrogen bonding capabilities for transcription and translation functions.
Solution Approach 2:
The patent uses acetyl groups as intermediary chemical structures that mediate between the reactive hydroxyl group and the RNA backbone. The 2′-O-acetyl group acts as a protective intermediary that reduces direct nuclease access to the ribose hydroxyl group while allowing essential biological functions to proceed. This intermediary modification resolves the contradiction by providing stability without completely altering RNA functionality.
2Productivity
If 2′-O-acetylated polyribonucleotides are administered at higher doses or repeatedly, then therapeutic efficacy is improved, but immunogenicity concerns arise
Solution Approach 1:
The patent converts the potentially harmful reactivity of the 2′-OH group into a benefit by acetylation. The modification that reduces immunogenicity (acetylation) also enhances stability and allows for repeated dosing. What could be seen as a chemical alteration that might increase immunogenicity actually reduces it by masking the reactive hydroxyl group that immune sensors would otherwise detect as foreign or damaged RNA.
Solution Approach 2:
The patent changes the chemical parameter of the 2′-OH group by acetylation, which simultaneously affects multiple properties: reduces immunogenicity, enhances stability, and enables higher dosing. This parameter change resolves the contradiction by making the RNA less recognizable to immune sensors while maintaining or enhancing therapeutic effectiveness.
3Duration of action of stationary object
If 2′-O-acetylated nucleotides are used in in vitro transcription, then RNA stability is improved, but the manufacturing process complexity increases
Solution Approach 1:
The patent applies preliminary action by incorporating 2′-O-acetylated nucleotides during the in vitro transcription process itself, rather than requiring post-transcriptional modification. The acetylated nucleotides are used as substrates for RNA polymerase during synthesis, ensuring that the RNA product is already stabilized with 2′-O-acetyl groups from the moment of creation. This preliminary incorporation simplifies the overall manufacturing process compared to subsequent chemical modification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
2′-O-acetylated ribonucleotides exhibit increased stability, reduced immunogenicity, and improved expression levels, enabling repeated dosing and lower dosing frequencies compared to unmodified RNAs.
Implementation Method 1
a ribonucleotide having a 2′-O-acetylated ribose can maintain crucial hydrogen bonding interactions necessary for transcription, translation, and duplex formation, while simultaneously having reduced reactivity that would otherwise promote RNA autohydrolysis and nuclease degradation
Implementation Method 2
a ribonucleotide having a 2′-O-acetylated ribose can maintain crucial hydrogen bonding interactions necessary for transcription, translation, and duplex formation
Data Source
AI summary
Disclosed herein is a modified ribonucleotide comprising a nucleoside comprising 2′-O-acetylated ribose, and polyribonucleotides comprising the same. Also provided herein are compositions comprising a polyribonucleotide of the present disclosure and methods of making and using the same.